78 related articles for article (PubMed ID: 21933637)
1. Cathepsin D expression in chronic plaque psoriasis: an immunohistochemical study.
Abdou AG; Maraee AH; Shoeib MA; Elsammie AA; Elnaidany NF
Acta Dermatovenerol Croat; 2011; 19(3):143-9. PubMed ID: 21933637
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study.
Abdou AG; Maraee AH; Sharaf A; Elnaidany NF
Ann Diagn Pathol; 2012 Jun; 16(3):177-84. PubMed ID: 22197545
[TBL] [Abstract][Full Text] [Related]
3. Processing of cathepsins L, B and D in psoriatic epidermis.
Kawada A; Hara K; Kominami E; Hiruma M; Noguchi H; Ishibashi A
Arch Dermatol Res; 1997 Jan; 289(2):87-93. PubMed ID: 9049042
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
[TBL] [Abstract][Full Text] [Related]
5. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N
Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis.
Alshenawy HA; Hasby EA
Cell Immunol; 2011; 269(2):115-9. PubMed ID: 21470599
[TBL] [Abstract][Full Text] [Related]
7. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
8. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
9. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
11. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
[TBL] [Abstract][Full Text] [Related]
12. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of GLUT-1 and Ki-67 in chronic plaque psoriasis.
Abdou AG; Maraee AH; Eltahmoudy M; El-Aziz RA
Am J Dermatopathol; 2013 Oct; 35(7):731-7. PubMed ID: 23392136
[TBL] [Abstract][Full Text] [Related]
14. Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris.
Bayramgürler D; Ozkara SK; Apaydin R; Erçin C; Bilen N
J Cutan Pathol; 2004 Oct; 31(9):586-94. PubMed ID: 15330989
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
Abdou AG; Hanout HM
J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt.
Amin MM; Azim ZA
Indian J Pathol Microbiol; 2012; 55(1):56-60. PubMed ID: 22499302
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis.
Henno A; Blacher S; Lambert C; Colige A; Seidel L; Noël A; Lapière C; de la Brassinne M; Nusgens BV
Br J Dermatol; 2009 Mar; 160(3):581-90. PubMed ID: 18945297
[TBL] [Abstract][Full Text] [Related]
19. Caspase 9 is decreased in psoriatic epidermis.
Oztaş P; Lortlar N; Oztaş MO; Omeroglu S; Gürer MA; Alli N
Acta Histochem; 2006; 108(6):497-9. PubMed ID: 17034836
[TBL] [Abstract][Full Text] [Related]
20. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
Durakovic C; Ray S; Holick MF
Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
